Acciones Endo Health Solutions Inc Nasdaq
Acciones
US29264F2056
Holding Companies
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Ventas 2022 | 2318,88 M 2162,26 M | Ventas 2023 | 2011,52 M 1875,66 M | Capitalización | 118 mil 110 mil |
---|---|---|---|---|---|
Resultado Neto 2022 | -2923 M -2725,59 M | Resultado Neto 2023 | -2450 M -2284,53 M | VE / Ventas 2022 | 2,97 x |
Deuda neta 2022 | 6868,72 M 6404,82 M | Deuda neta 2023 | 7407 M 6906,74 M | VE / Ventas 2023 | 3,68 x |
P/E ratio 2022 |
-0,01
x | P/E ratio 2023 |
-
| Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 99,35 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Blaise A Coleman
CEO | Chief Executive Officer | 50 | 01/01/15 |
Mark Bradley
DFI | Director of Finance/CFO | 54 | 01/01/07 |
Cheryl Stouch
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michael Hyatt
BRD | Director/Board Member | 78 | 01/02/14 |
Director/Board Member | 77 | 28/02/14 | |
Jennifer Chao
BRD | Director/Board Member | 54 | 17/02/21 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+166,80 % | 6382,55 M | |
+1,65 % | 1010,16 M | |
+2,05 % | 981 M | |
+41,91 % | 872 M | |
+24,28 % | 812 M | |
+1,72 % | 664 M | |
+1,80 % | 617 M | |
-.--% | 600 M | |
+36,55 % | 622 M |